Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
14.86
-0.04 (-0.27%)
Apr 24, 2025, 2:45 PM CST
Shenzhen YHLO Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | 2019 - 2020 |
Net Income | - | 355.01 | 1,012 | 204.75 | 210.53 | Upgrade
|
Depreciation & Amortization | - | 194.93 | 144.73 | 99.32 | 69.5 | Upgrade
|
Other Amortization | - | 15.63 | 29.91 | 5.21 | 4.23 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -2.07 | 3.39 | 0.2 | 0.02 | Upgrade
|
Asset Writedown & Restructuring Costs | - | 9.08 | 10.33 | - | 1.25 | Upgrade
|
Loss (Gain) From Sale of Investments | - | -85.35 | -59.84 | 2.82 | -0.19 | Upgrade
|
Provision & Write-off of Bad Debts | - | 7.5 | 11.07 | 2.6 | 1.95 | Upgrade
|
Other Operating Activities | - | -11.46 | 114.83 | 26.53 | 22.96 | Upgrade
|
Change in Accounts Receivable | - | 12.93 | -190.33 | -54.96 | -58.25 | Upgrade
|
Change in Inventory | - | -101.71 | -340.52 | -67.37 | -20.87 | Upgrade
|
Change in Accounts Payable | - | -477.25 | 843.34 | 43.78 | 45.42 | Upgrade
|
Change in Other Net Operating Assets | - | 13.49 | 21.41 | - | - | Upgrade
|
Operating Cash Flow | - | -73.19 | 1,583 | 259.62 | 282.16 | Upgrade
|
Operating Cash Flow Growth | - | - | 509.80% | -7.99% | 312.87% | Upgrade
|
Capital Expenditures | - | -662.71 | -565.37 | -372.66 | -189.39 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.06 | 0.03 | - | 0.21 | Upgrade
|
Cash Acquisitions | - | - | -6.3 | - | - | Upgrade
|
Divestitures | - | -21.57 | - | - | - | Upgrade
|
Investment in Securities | - | 22.25 | -280.48 | -91.68 | - | Upgrade
|
Other Investing Activities | - | 27.1 | -17.71 | 3.27 | 21.43 | Upgrade
|
Investing Cash Flow | - | -634.88 | -869.83 | -461.08 | -167.76 | Upgrade
|
Long-Term Debt Issued | - | 530.09 | 683.38 | 367.96 | 660 | Upgrade
|
Long-Term Debt Repaid | - | -287.69 | -449.87 | -454.13 | -629.72 | Upgrade
|
Net Debt Issued (Repaid) | - | 242.4 | 233.51 | -86.17 | 30.28 | Upgrade
|
Issuance of Common Stock | - | 17.26 | - | 561.76 | - | Upgrade
|
Common Dividends Paid | - | -282.53 | -169 | -10.9 | -36.23 | Upgrade
|
Other Financing Activities | - | 3.61 | -51.03 | -17.15 | -2.81 | Upgrade
|
Financing Cash Flow | - | -19.26 | 13.47 | 447.55 | -8.76 | Upgrade
|
Foreign Exchange Rate Adjustments | - | 3.98 | 10.25 | -1.41 | -2.61 | Upgrade
|
Net Cash Flow | - | -723.34 | 737.05 | 244.68 | 103.03 | Upgrade
|
Free Cash Flow | - | -735.9 | 1,018 | -113.04 | 92.76 | Upgrade
|
Free Cash Flow Margin | - | -35.84% | 25.57% | -9.60% | 9.29% | Upgrade
|
Free Cash Flow Per Share | - | -1.28 | 1.79 | -0.21 | 0.18 | Upgrade
|
Cash Income Tax Paid | - | 145.81 | 234.29 | 80.03 | 52.74 | Upgrade
|
Levered Free Cash Flow | - | -966.27 | 855.65 | -122.11 | -10.51 | Upgrade
|
Unlevered Free Cash Flow | - | -962.36 | 860.91 | -115.1 | -2.27 | Upgrade
|
Change in Net Working Capital | - | 658.35 | -514.03 | -21.26 | 51.12 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.